1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWING ELDERLY POPULACE
3.2.2. GROWING NEUROREHABILITATION DEVICE WEARABLES AND ROBOTICS
3.2.3. SIGNIFICANT RISE IN NEUROLOGICAL DISEASES
3.2.4. TECHNOLOGICAL ADVANCEMENTS IN THE NEUROREHABILITATION DEVICE
3.3. KEY RESTRAINTS
3.3.1. HIGH COST OF TREATMENT
3.3.2. STRINGENT REGULATIONS

4. KEY ANALYTICALS
4.1. PORTER’S FIVE FORCES ANALYSIS
4.1.1. THREAT OF NEW ENTRANTS
4.1.2. THREAT OF SUBSTITUTES
4.1.3. BARGAINING POWER OF BUYER
4.1.4. BARGAINING POWER OF SUPPLIER
4.1.5. INTENSITY OF COMPETITIVE RIVALRY
4.2. SUPPLY CHAIN ANALYSIS
4.3. TIMELINE OF NEUROREHABILITATION DEVICE
4.4. KEY BUYING CRITERIA
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
4.7. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT
5.1. NEURO-ROBOTIC SYSTEM
5.2. BRAIN COMPUTER INTERFACE
5.3. WEARABLE DEVICE
5.4. NON-INVASIVE STIMULATOR
5.5. OTHER PRODUCTS

6. MARKET BY APPLICATION
6.1. STROKE
6.2. CEREBRAL PALSY
6.3. PARKINSON’S DISEASE
6.4. MULTIPLE SCLEROSIS
6.5. OTHER APPLICATIONS

7. MARKET BY END-USER
7.1. HOSPITAL/CLINIC
7.2. RESEARCH INSTITUTE
7.3. COGNITIVE CARE CENTER
7.4. OTHER END-USER

8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. THE UNITED STATES
8.1.2. CANADA

9. COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.2. BIOMETRICS LTD
9.3. BIONIK LABORATORIES CORP
9.4. BIOXTREME
9.5. ECTRON LIMITED
9.6. EKSO BIONICS HOLDINGS INC
9.7. HELIUS MEDICAL TECHNOLOGIES
9.8. HOKOMA AG
9.9. KINESTICA
9.10. KINOVA
9.11. MEDTRONIC INC
9.12. NEUROSTYLE PTE LTD
9.13. TYROMOTION GMBH